News

Insights from
our practice

579 articles

Jul 18, 2019

combit versus commit

Will conceptual differences between conflicting signs neutralize acoustic similarities and what does it mean for the injunctive relief if the understanding of the relevant consumers differs throughout the European…

Read more →

Feb 4, 2019

New, but obvious delivery form

In the prior art a study is known in which the patented active ingredient (fulvestrant) is already being used to treat breast cancer. Although this study only describes subcutaneous injections, it is logical to use this…

Read more →
Mitglieder des Teams von SONN Patentanwälte
Get in touch

Let us discuss the legal issues that matter to you.

We keep a close eye on recent legal developments, provide up-to-date advice, and develop strategies that turn new decisions to your advantage.

Contact us →